No Data
No Data
Express News | Hims & Hers Health Shares Are Trading Lower Following a Report Indicating the FDA Issued a Warning on Compounding GLP-1 Adverse Events
FDA Issues Warning on Compounded Versions of Novo Nordisk's Semaglutide
Can Hims & Hers Health (HIMS) Run Higher on Rising Earnings Estimates?
How Is The Market Feeling About Hims & Hers Health?
Hims & Hers Health Insider Sold Shares Worth $549,992, According to a Recent SEC Filing
Express News | What's Going On With Hims & Hers Shares Today?
No Data